Dualsteric GPCR targeting and functional selectivity: The paradigmatic M2 muscarinic acetylcholine receptor

Drug Discovery Today: Technologies

Volumn 10, Issue 2, 2013, Pages

  Bock, Andreas ^a   Mohr, Klaus ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR;

ALLOSTERISM; BINDING AFFINITY; BINDING SITE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLEX FORMATION; HIGH THROUGHPUT SCREENING; LOSS OF FUNCTION MUTATION; PROTEIN CONFORMATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ANIMALS; BINDING SITES; LIGANDS; PROTEIN BINDING; RECEPTOR, MUSCARINIC M2;

EID: 84879884493     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2012.12.003     Document Type: Review

References (49)

1. J.P. Overington How many drug targets are there? Nat. Rev. Drug Discov. 5 2006 993 996
2. M.C. Lagerstrom, and H.B. Schioth Structural diversity of G protein-coupled receptors and significance for drug discovery Nat. Rev. Drug Discov. 7 2008 339 357
3. S.M. DeWire β-Arrestins and cell signaling Ann. Rev. Physiol. 69 2007 483 510
4. L. Shi, and J. Javitch The binding site of aminergic G protein-coupled receptors Ann. Rev. Pharmacol. Toxicol. 42 2002 437 467
5. 1 muscarinic acetylcholine receptor Receptors Channels 9 2003 215 228
6. 2 muscarinic acetylcholine receptor bound to an antagonist Nature 482 2012 547 551
7. 3 muscarinic acetylcholine receptor Nature 482 2012 552 556
8. 4 mAChR modulates hippocampal synaptic transmission Nat. Chem. Biol. 4 2008 42 50
9. P.J. Conn Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders Trends Pharmacol. Sci. 30 2009 148 155
10. J. Wess Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development Nat. Rev. Drug Discov. 6 2007 721 733
11. R. Morphy, and Z. Rankovic Designed multiple ligands. An emerging drug discovery paradigm J. Med. Chem. 48 2005 6523 6543
12. P.S. Portoghese Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists Trends Pharmacol. Sci. 10 1989 230 235
13. C. Valant A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand J. Biol. Chem. 283 2008 29312 29321
14. J. Antony Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity FASEB J. 23 2009 442 450
15. K. Mohr Rational design of dualsteric GPCR ligands: quests and promise Br. J. Pharmacol. 159 2010 997 1008
16. A.P. Roszkowski An unusual type of sympathetic ganglionic stimulant J. Pharmacol. Exp. Ther. 132 1961 156 170
17. M.P. Caulfield, and N.J.M. Birdsall International union of pharmacology, XVII. Classification of muscarinic acetylcholine receptors Pharm. Rev. 50 1998 279 290
18. J. Jakubík Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors Mol. Pharmacol. 52 1997 172 179
19. 15 J. Pharmacol. Exp. Ther. 321 2007 1193 1207
20. F.J. Mitchelson The pharmacology of McN-A-343 Pharmacol. Ther. 135 2012 216 245
21. 2 muscarinic receptor Mol. Pharmacol. 72 2007 291 302
22. A.L. Clark, and F. Mitchelson The inhibitory effect of gallamine on muscarinic receptors Br. J. Pharmacol. 58 1976 323 331
23. J.M. Stockton Modification of the binding properties of muscarinic receptors by gallamine Mol. Pharmacol. 23 1983 551 557
24. K.L. Jepsen Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication Pharmacol. Toxicol. 63 1988 163 168
25. 2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner Mol. Pharmacol. 79 2011 389 399
26. 2 agonist molecules for the treatment of chronic obstructive pulmonary disease Future Med. Chem. 3 2011 1585 1605
27. C. Dallanoce Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M Bioorg. Med. Chem. 7 1999 1539 1547
28. A. Bock The allosteric vestibule of a seven transmembrane helical receptor controls G protein-coupling Nat. Commun. 3 2012 1044 10.1038/ncomms2028
29. C. Valant The best of both worlds? Bitopic orthosteric/allosteric ligands of G protein-coupled receptors Ann. Rev. Pharmacol. Toxicol. 52 2012 153 178
30. 2 receptors Mol. Pharmacol. 64 2003 180 190
31. R.A. Leppik Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor Mol. Pharmacol. 45 1994 983 990
32. 5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors Mol. Pharmacol. 64 2003 21 31
33. 2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3-phthalimidopropyl) ammonium]dibromide Mol. Pharmacol. 68 2005 769 778
34. 2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias J. Biol. Chem. 285 2010 7459 7474
35. T. Kenakin, and L.J. Miller Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery Pharmacol. Rev. 62 2010 265 304
36. S. Rajagopal Teaching old receptors new tricks: biasing seven-transmembrane receptors Nat. Rev. Drug Discov. 9 2010 373 386
37. E. Reiter Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors Annu. Rev. Pharmacol. Toxicol. 52 2012 179 197
38. T.P. Kenakin Biased signalling and allosteric machines: new vistas and challenges for drug discovery Br. J. Pharmacol. 165 2012 1659 1669
39. T. Kenakin A simple method for quantifying functional selectivity and agonist bias ACS Chem. Neurosci. 3 2012 193 203
40. J.W. Black, and P. Leff Operational models of pharmacological agonism Proc. R. Soc. Lond. B: Biol. Sci. 220 1983 141 162
41. R. Schröder Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements Nat. Biotechnol. 28 2010 943 949
42. R. Schröder Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells Nat. Protocols 6 2011 1748 1760
43. H. Lüllmann Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds Eur. J. Pharmacol. 6 1969 241 247
44. 2 422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity Mol. Pharmacol. 70 2006 181 193
45. T. Disingrini Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors J. Med. Chem. 49 2005 366 372
46. J. Klöckner Convergent, short synthesis of the muscarinic superagonist iperoxo Tetrahedron Lett. 51 2010 3470 3472
47. 2 acetylcholine receptor Br. J. Pharmacol. 2012 10.1111/bph.12003
48. R. Narlawar Hybrid ortho/allosteric ligands for the adenosine A1 receptor J. Med. Chem. 53 2010 3028 3037
49. 2 muscarinic acetylcholine receptors Mol. Pharmacol. 72 2007 463 476